Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of NRL972 in Hepatic Cirrhosis
NCT00794482Phase 3Completed
- Sponsor
- Norgine
- Start
- Mar 2008
- Primary completion
- Jun 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of fluorescein lisicol in Hepatic cirrhosis, sponsored by Norgine. Started Mar 2008; status: completed.
02
Drugs
fluorescein lisicol
03
Conditions
Hepatic cirrhosis
Beyond the preview
Go deeper on NCT00794482.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00794482.